Galectin 10 Protein (AA 52-142) (GST tag)
-
- Antigène Voir toutes Galectin 10 (CLC) Protéines
- Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 52-142
-
Origine
- Humain
-
Source
- Wheat germ
- Purification/Conjugué
- Cette Galectin 10 protéine est marqué à la GST tag.
- Application
- Western Blotting (WB), ELISA, Antibody Array (AA), Affinity Purification (AP)
- Fonction
- CLC (Human) Recombinant Protein (Q01)
- Séquence
- FHFQVCFGRR VVMNSREYGA WKQQVESKNM PFQDGQEFEL SISVLPDKYQ VMVNGQSSYT FDHRIKPEAV KMVQVWRDIS LTKFNVSYLK R
- Attributs du produit
- Human CLC partial ORF ( NP_001819.2, 52 a.a. - 142 a.a.) recombinant protein with GST-tag at N-terminal.
- Purification
- in vitro wheat germ expression system
- Top Product
- Discover our top product CLC Protéine
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Preparation method: in vitro, wheat germ expression system
Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue. - Restrictions
- For Research Use only
-
- Buffer
- 50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.
- Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
- Stock
- -80 °C
- Stockage commentaire
- Best use within three months from the date of receipt of this protein.
-
- Antigène
- Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))
- Autre désignation
- CLC (CLC Produits)
- Synonymes
- GAL10 Protein, Gal-10 Protein, LGALS10 Protein, LGALS10A Protein, LPPL_HUMAN Protein, Clcp Protein, gal-10 Protein, Bsf3 Protein, CLC Protein, GAL 10 Protein, Gal-8 Protein, Gal8 Protein, Charcot-Leyden crystal galectin Protein, Charcot-Leyden crystal protein Protein, cardiotrophin-like cytokine factor 1 Protein, avian beta-defensin 10 Protein, CLC Protein, Clc Protein, Clcf1 Protein, AvBD10 Protein
- Sujet
-
Full Gene Name: Charcot-Leyden crystal protein
Synonyms: LGALS10,LPPL_HUMAN,MGC149659 - ID gène
- 1178
- NCBI Accession
- NM_001828
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-